CHROMOGENICS RESOLVES ON A DIRECTED ISSUE OF UNITS TO GUARANTORS IN CONNECTION WITH THE COMPLETED RIGHTS ISSUE
PRESS RELEASE THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CHROMOGENICS AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.The Board of Directors of ChromoGenics AB (publ) ("ChromoGenics" or the "Company") has today, on 7 December 2022,